Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

BWV

Blue Water Biotech (BWV)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BWV
DataOraFonteTitoloSimboloCompagnia
21/12/202322:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BWVBlue Water Biotech Inc
19/12/202313:00GlobeNewswire Inc.Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to ShareholdersNASDAQ:BWVBlue Water Biotech Inc
18/12/202313:00GlobeNewswire Inc.Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™NASDAQ:BWVBlue Water Biotech Inc
17/11/202323:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BWVBlue Water Biotech Inc
02/11/202312:00GlobeNewswire Inc.Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology CompanyNASDAQ:BWVBlue Water Biotech Inc
01/11/202312:00GlobeNewswire Inc.Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)NASDAQ:BWVBlue Water Biotech Inc
30/10/202312:00GlobeNewswire Inc.Blue Water Biotech Issues Letter to ShareholdersNASDAQ:BWVBlue Water Biotech Inc
10/10/202315:00GlobeNewswire Inc.Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFONASDAQ:BWVBlue Water Biotech Inc
28/08/202322:30GlobeNewswire Inc.Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-QNASDAQ:BWVBlue Water Biotech Inc
15/08/202323:22Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:BWVBlue Water Biotech Inc
10/08/202315:00GlobeNewswire Inc.Blue Water Biotech and Copay Consultants Collaborate to Build Copay Assistance Programs for Blue Water’s Commercial ProductsNASDAQ:BWVBlue Water Biotech Inc
03/08/202319:02GlobeNewswire Inc.Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross ProceedsNASDAQ:BWVBlue Water Biotech Inc
01/08/202314:00GlobeNewswire Inc.Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross ProceedsNASDAQ:BWVBlue Water Biotech Inc
31/07/202315:00GlobeNewswire Inc.Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to PhysiciansNASDAQ:BWVBlue Water Biotech Inc
25/07/202315:00GlobeNewswire Inc.Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®NASDAQ:BWVBlue Water Biotech Inc
17/07/202315:00GlobeNewswire Inc.Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch ActivitiesNASDAQ:BWVBlue Water Biotech Inc
11/07/202315:00GlobeNewswire Inc.Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage SupportNASDAQ:BWVBlue Water Biotech Inc
06/07/202323:05GlobeNewswire Inc.Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved ProductsNASDAQ:BWVBlue Water Biotech Inc
06/07/202313:30GlobeNewswire Inc.Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product PortfolioNASDAQ:BWVBlue Water Biotech Inc
29/06/202316:35Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:BWVBlue Water Biotech Inc
28/06/202314:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BWVBlue Water Biotech Inc
28/06/202313:55GlobeNewswire Inc.Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle PlatformNASDAQ:BWVBlue Water Biotech Inc
21/06/202313:30GlobeNewswire Inc.Blue Water Biotech Collaborates with IQVIA to Build Medical Sales Representative Team to Market Commercial Product PortfolioNASDAQ:BWVBlue Water Biotech Inc
14/06/202313:30GlobeNewswire Inc.Blue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across Various Treatment AreasNASDAQ:BWVBlue Water Biotech Inc
13/05/202300:32GlobeNewswire Inc.Blue Water Biotech Reports First Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:BWVBlue Water Biotech Inc
10/05/202318:15GlobeNewswire Inc.Blue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NYNASDAQ:BWVBlue Water Biotech Inc
05/05/202312:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BWVBlue Water Biotech Inc
28/04/202323:17Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:BWVBlue Water Biotech Inc
26/04/202323:23Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BWVBlue Water Biotech Inc
26/04/202321:44GlobeNewswire Inc.Blue Water Biotech Appoints Board-Certified Urologist Jay Newmark, M.D., MBA as Chief Medical OfficerNASDAQ:BWVBlue Water Biotech Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BWV
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network